Listen to experienced IP professionals discuss how best to right size your IP spending to strike the right balance between reducing IP costs and building your company’s IP position and technology value. This panel discusses how the changing IP regulatory environment may impact these decisions.
Moderator: John T. Gutkoski
Panelists:
David Cerveny, Vice President Intellectual Property and General Counsel, ConforMIS, Inc.
Wendy Rieder, General Counsel and Vice President Intellectual Property and Legal Affairs, Synta Pharmaceuticals Corp.
Steve Tannenbaum, Executive Vice President and Chief Financial Officer, Collegium Pharmaceutical, Inc.
Related Insights
April 10, 2026
Energy Current
Mexico Plans to Reactivate Fracking by 2027
President Claudia Sheinbaum announced on April 8 a significant shift in Mexico’s energy policy by unveiling a project to exploit natural…
April 10, 2026
Energy Current
Proposed Legislation Pending in Oklahoma State Legislature Would Impact Responsibility for Payment of Costs Associated with Data Centers and Other Large Load Facilities
Several proposed bills targeting data centers have been proposed in the 2026 session of the Oklahoma State Legislature. Most of these…
April 9, 2026
Health Care Law Today
Hemp Product Use in Medicare: CMS Greenlights Pilot Program under the Substance Access Beneficiary Engagement Incentive
On April 1, 2026, the Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center (CMMI), officially launched a new pilot program which allows participants in specific CMS programs to offer eligible hemp products to eligible Medicare beneficiaries.